AaronPScholnikMDFACP

PubMed

• 195 citations
  National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
  Otis W. Brawley, Llewellyn J. Cornelius, Linda Edwards, Vanessa Northington Gamble, Bettye L. Green, Charles E. Inturrisi, Andra H. James, Danielle Laraque, Magda D. M...> ;Annals of Internal Medicine. 2008 Jun 17
• 15 citations
  NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
  Otis W. Brawley, Llewellyn J. Cornelius, Linda Edwards, Vanessa Northington Gamble, Bettye L. Green, Charles E. Inturrisi, Andra H. James, Danielle Laraque, Magda H. M...> ;NIH Consensus and State-of-the-Science Statements. 2008 Feb 27
• 45 citations
  Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome.
  Renu Pandit, Aaron Scholnik, Louis Wulfekuhler, Nikolay V. Dimitrov> ;American Journal of Hematology. 2007 Mar 1
• 3 citations
  Improved Outcome With Dose-Dense Chemotherapy
  Bruce Keith, Rob Hall, Aaron Scholnik> ;Journal of Clinical Oncology. 2004 Feb 15
• 18 citations
  Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58
  Roy E. Smith, Stewart J. Anderson, Ann M. Brown, Aaron P. Scholnik, Ajit M. Desai, Carl G. Kardinal, Barry C. Lembersky, Eleftherios P. Mamounas> ;Clinical Breast Cancer. 2002 Dec 1
• 3 citations
  High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancer.
  Aaron Scholnik, Daniel J. Arnold, Wendy S. Walker, Paula Schwenke, Leif G. Suhrland, Ernie P. Balcueva, Nikolay V. Dimitrov> ;American Journal of Clinical Oncology. 1988 Oct 1
• Join now to see all

Journal Articles

• National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease  
  Otis W. Brawley, MD, Llewellyn J. Cornelius, PhD, LCSW; Linda R. Edwards, MD, Vanessa Northington Gamble, MD, PhD, Bettye L. Green, RN, Charles Inturrisi, PhD, Andrea ..., Annals of Internal Medicine, 6/17/2008
• Non-small-cell Lung Cancer Associated with Excessive Eosinophilia and Secretion of Interleukin-5 as a Paraneoplastic Syndrome  
  Pandit, R., Scholnik, A., Wulfekuhler, L., Dimitrov, N., Am J Hematology, 12/7/2006
• To Refer or Not to Refer: Factors that Affect Primary Care Provider Referral of Patients with Cancer to Clinical Treatment Trials  
  Sherwood P.R., Given, B.A., Scholnik, A., Given, C.W., J Cancer Educ, 3/1/2004
• Improved Outcome with Dose-Dense Chemotherapy  
  Keith, B., Hall, R., Scholnik, A., J Clin Oncol, 2/15/2004
• Phase II Trial of a Doxorubicin/Docetaxel/Cyclophosphamide Triplet for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58  
  Smith, R.E., Anderson, S.J., Brown, A., Scholnik, A.P., Desai, A.M., Kardinal, C.G., Lembersky, B.C., & Mamounas, E.P., Clinical Breast Cancer, 1/1/2002
• When the Art and Science of Medicine Collide: The Ethics of Incorporating Clinical Trials into a Physician's Practice  
  Scholnik, A.P., Research Integrity, 1/1/2000
• A Phase II Randomized Trial of Intermittent Leukocyte Interferon and High Dose Chlorambucil in the Treatment of non-Hodgkin's Lymphoma Resistant to Combination Therapy  
  Scholnik A.P., Clark R.H., Dimitrov N.V., Axelson J.A., Charamella L.J., Walker W., Balcueva E.P., Cook D.A., and Stott P.B., American Journal of Clinical Oncology, 1/1/1989
• High-Dose Folinic Acid and 5-FU in the Treatment of Advanced Colon Cancer  
  Scholnik A.P., Arnold D.J., Walker W., Schwenke P., Suhrland L.G., Balcueva E.P., and Dimitrov N.V., American Journal of Clinical Oncology, 1/1/1988
• Fetal Hemoglobin in Various Malignancies  
  Scholnik AP, Chudwin DS, Rucknagel DL, Waldman TA, and McIntire KR, Acta Haematologica, 1/1/1977
• A Direct Cytochemical Method for the Identification of Lysozyme in Various Tissues  
  Scholnik AP, and Kass L, Journal of Histochemistry and Cytochemistry, 1/1/1973
• Hereditary Elliptocytosis  
  Scholnik AP, Van Tillburg C, and Hoffman G, The Cleveland Clinic Quarterly, 1/1/1973
• Hemolysis in Hereditary Elliptocytosis - A Family Study  
  Scholnik AP, Van Tillburg C, Hoffman G, and Battle J, Ohio State Medical Journal, 1/1/1971
• Join now to see all

Books/Book Chapters

• Advances in Cancer Control: Health Care Financing and Research 
  Chapter: A New Mechanism for Physician Participation in a Tumor Board 
  Scholnik A.P., Arnold D.J., Gordon D.C., Wiggins J.D., and Voorhees E.G.Editors: L.E. Mortensen, P.F. Engstrom and P.N. Anderson.Alan R. Lis, Inc., New York1986

Abstracts/Posters

• Psychological Characteristics of Patients Who Enter Clinical Trials
  Scholnik, A.P., Given, C.W., Chapman, R., Gadgeel, S.M., Decker, D., Axelson, J., Proceedings of the American Society of Clinical Oncology, J Clin Onc, 5/31/2003
• Psychological Aspects of Patients Who Enter Clinical Trials
  Scholnik, A.P., ASCO Annual Meeting, Chicago, IL, 5/31/2003
• Characteristics of Patients Who Enter Clinical Trials
  Scholnik, A., Given, C.W., Given, B., Patterson, P., Ping, J., Michigan Cancer Consortium Annual Meeting, Ann Arbor, Michigan, 9/13/2002
• Primary Care Providers' Attitudes about Cancer Clinical Treatment Trials
  Given, B., Scholnik, A., Given, C.W., Patterson, P., Rahbar, M., and Sherwood, P., Michigan Cancer Consortium Annual Meeting, Ann Arbor, Michigan, 9/12/2002
• Effect of Taxol Duration of Infusion in Advanced Breast Cancer (ABC): Results from NSABP B-26 Trial Comparing 3- to 24-HR Infusion of High-Dose Taxol
  Mamounas, E., Brown, A., Smith, R., Lembersky, B., Fisher, B., Wickerham, D.L., Wolmark, N., Atkins, J., Shibata, H., Baez, L., DeFusco, P., Davila, E., Thirlwell, M.,..., Proceedings of the American Society of Clinical, 1/1/2002
• Results of Treatment with Weekly Mitoxantrone (Mx) And Paclitaxel (T) Plus GM-CSF in Patients with Advanced Breast Cancer (BC) And Is Effect on Dendritic Cell (DC) Counts
  Scholnik, A.P., Renshaw, F.G., Singh, T.T., Balcueva, E., Dimitrov, N.V., Huard, T., Proceedings of the American Society of Clinical Oncology, 1/1/2002
• Treatment of Lymphoproliferative Malignancy Chemotherapy Failures with Human Leukocyte Interferon
  Rapson CR, Scholnik AP, Stoutenborough KA, Schwartz KA, Blood, 1/1/1983
• Join now to see all

Lectures

• A Common Lexicon for the Pathology Reporting of Breast, Prostate and Colorectal Cancers 
  Novi, MI - 9/1/2003
• Primary Care Provider's Attitudes about Cancer Treatment Clinical Trials 
  Ann Arbor, Michigan - 9/13/2002
• Characteristics of Patients Who Enter Clinical Trials 
  Karmanos Cancer Center. Detroit, Michigan - 9/11/2002
• Primary Care Providers Attitudes about Cancer Clinical Treatment Trials 
  East Lansing, Michigan - 9/4/2002
• Expanding Oncological Services to Rural Hospitals: A Decentralization Multidisciplinary Approach 
  Washington, D.C. - 3/15/1988
• Marijuana Therapy Research Workshop 
  Michigan State University, Lansing, MI - 4/1/1981
• Join now to see all

Other

• Development of a Cancer Program in a Comprehensive Community Hospital 
  Scholnik, A.P., A Michigan Hospital Association Teleconference, National Broadcast
  10/31/1985